|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.51 USD | -9.07% |
|
-6.21% | -58.26% |
| Capitalization | 1.6TCr 1.52TCr 1.41TCr 1.25TCr 2.26TCr 1,35600Cr 2.51TCr 18TCr 6.48TCr 56TCr 6TCr 5.87TCr 2,42900Cr | P/E ratio 2024 * |
-4.43x | P/E ratio 2025 * | -4.64x |
|---|---|---|---|---|---|
| Enterprise value | 784.76Cr 746.94Cr 692.2Cr 615.67Cr 1.11TCr 67TCr 1.23TCr 8.62TCr 3.18TCr 27TCr 2.95TCr 2.88TCr 1,19300Cr | EV / Sales 2024 * |
2.38x | EV / Sales 2025 * | 3.93x |
| Free-Float |
90.48% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Moderna, Inc.
More recommendations
More press releases
More news
| 1 day | -9.07% | ||
| 1 week | -6.21% | ||
| Current month | -3.60% | ||
| 1 month | -11.36% | ||
| 3 months | -45.82% | ||
| 6 months | -72.51% | ||
| Current year | -58.26% |
1 week
41.06
47.41
1 month
35.8047.41
Current year
35.80170.47
1 year
35.80170.47
3 years
35.80321.31
5 years
17.68497.49
10 years
11.54497.49
| Director | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 51 | 01/03/2011 |
James Mock
DFI | Director of Finance/CFO | 47 | 06/09/2022 |
Stephen Hoge
PSD | President | 48 | 01/02/2015 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Sagan
BRD | Director/Board Member | 65 | 01/06/2018 |
Noubar Afeyan
CHM | Chairman | 61 | 01/02/2012 |
Stéphane Bancel
BRD | Director/Board Member | 51 | 01/03/2011 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 5.66% | 0 M€ | 0.00% | - | |
| 4.69% | 2 M€ | -.--% | ||
| 4.08% | 0 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -9.07% | -6.21% | -48.32% | -84.75% | 1.76TCr | ||
| +0.85% | -1.06% | +58.93% | -30.68% | 4.27TCr | ||
| -1.57% | +0.70% | -5.61% | -24.51% | 3.75TCr | ||
| +4.00% | -1.35% | +8.59% | -8.45% | 2.53TCr | ||
| -1.49% | +1.12% | -20.74% | -21.07% | 1.81TCr | ||
| -1.30% | -2.13% | +49.90% | +93.67% | 1.64TCr | ||
| -0.36% | +1.45% | +12.90% | -34.39% | 1.23TCr | ||
| -2.92% | -0.12% | +20.75% | +65.72% | 1.09TCr | ||
| -2.33% | -2.09% | -3.62% | -44.81% | 1.03TCr | ||
| +3.95% | +5.54% | +6.99% | -17.64% | 985.05Cr | ||
| Average | -1.02% | +0.81% | +7.98% | -10.69% | 2.01TCr | |
| Weighted average by Cap. | -0.75% | +0.62% | +12.62% | -15.53% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 329.15Cr 313.29Cr 290.33Cr 258.23Cr 466.15Cr 28TCr 516.61Cr 3.62TCr 1.33TCr 11TCr 1.24TCr 1.21TCr 50TCr | 296.52Cr 282.23Cr 261.55Cr 232.63Cr 419.94Cr 25TCr 465.39Cr 3.26TCr 1.2TCr 10TCr 1.11TCr 1.09TCr 45TCr |
| Net income | -357.32Cr -340.1Cr -315.17Cr -280.33Cr -506.04Cr -30TCr -560.81Cr -3.92TCr -1.45TCr -12TCr -1.34TCr -1.31TCr -54TCr | -347.55Cr -330.79Cr -306.55Cr -272.66Cr -492.2Cr -29TCr -545.47Cr -3.82TCr -1.41TCr -12TCr -1.3TCr -1.28TCr -53TCr |
| Net Debt | -812.61Cr -773.45Cr -716.77Cr -637.52Cr -1.15TCr -69TCr -1.28TCr -8.93TCr -3.29TCr -28TCr -3.05TCr -2.98TCr -1,23600Cr | -433.25Cr -412.37Cr -382.15Cr -339.9Cr -613.58Cr -37TCr -679.99Cr -4.76TCr -1.76TCr -15TCr -1.63TCr -1.59TCr -66TCr |
More financial data
* Estimated data
Employees
5,600
Calendar
20/02/2025
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 41.51 $ | -9.07% | 10,423,383 |
| 09/24/09 | 45.65 $ | +2.72% | 7,292,460 |
| 06/24/06 | 44.44 $ | +3.49% | 8,742,718 |
| 05/24/05 | 42.94 $ | +3.15% | 8,084,242 |
| 04/24/04 | 41.63 $ | -2.23% | 5,010,891 |
Delayed Quote Nasdaq, December 11, 2024 at 02:30 am IST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
45.65USD
Average target price
75.77USD
Spread / Average Target
+65.98%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MRNA Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition